Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy

Drug Resistance Updates

Volumn 8, Issue 1-2, 2005, Pages 85-97

  Efferth, Thomas ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Angiogenesis; Apoptosis; Artemisinin; Multidrug resistance; Oxidative stress; Pharmacogenomics; Sesquiterpene lactones; Traditional Chinese medicine

Indexed keywords

1,2,4 TRIOXANE DERIVATIVE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ARTEANUINE B; ARTEETHER; ARTEFLENE; ARTEMETHER; ARTEMISIN; ARTEMISIN DERIVATIVE; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTEMISITENE; ARTESUNATE; CAMPTOTHECIN; CISPLATIN; DAUNORUBICIN; DEOXOARTEMISININ; DEOXYDOXORUBICIN; DIHYDROARTEMISININ; DIHYDROFOLATE REDUCTASE INHIBITOR; DNA TOPOISOMERASE INHIBITOR; DOCETAXEL; DOXORUBICIN; DRUG CARRIER; EPIRUBICIN; ERLOTINIB; FERROSANOL; FERROUS SULFATE; GYRASE INHIBITOR; IDARUBICIN; MALTOSYL BETA CYCLODEXTRIN; METHOTREXATE; OXALIPLATIN; PACLITAXEL; PIRARUBICIN; PLATINUM DERIVATIVE; TETRAPLATIN; TOPOTECAN; TRANSFERRIN; TRIMETREXATE; UNCLASSIFIED DRUG; VALRUBICIN; VINBLASTINE;

ANGIOGENESIS; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER PREVENTION; CARDIOTOXICITY; CELL PROLIFERATION; CROSS RESISTANCE; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; DRUG SENSITIVITY; DRUG TARGETING; GENE CONTROL; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; KNOCKOUT GENE; MALARIA; MOTOR DYSFUNCTION; MULTIDRUG RESISTANCE; NEUROPATHY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PHARMACOGENOMICS; PLASMODIUM; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEIN TARGETING; REVIEW; SIDE EFFECT; VALIDATION PROCESS;

EID: 20444365167     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drup.2005.04.003     Document Type: Article

References (128)

1. W. Asawamahasakda, I. Ittarat, Y.M. Pu, H. Ziffer, and S.R. Meshnick Reaction of antimalarial endoperoxides with specific parasite proteins Antimicrob. Agents Chemother. 38 1994 1854 1858
2. E. Aulbert, W. Disselhoff, H. Sorje, E. Schulz, and D. Gericke Lysosomal accumulation of 67 kDa-transferrin in malignant tumors in relation to their growth rate Eur. J. Cancer 16 1980 1217 1232
3. A.S. Baldwin Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB J. Clin. Invest. 107 2001 241 246
4. J. Baselga Why the epidermal growth factor receptor? The rationale for cancer therapy Oncologist 7 2002 2 8
5. A.C. Beekman, H.J. Woerdenbag, W. van Uden, N. Pras, A.W. Konings, and H.V. Wikstrom Stability of artemisinin in aqueous environments: impact on its cytotoxic action to Ehrlich ascites tumour cells J. Pharm. Pharmacol. 49 1997 1254 1258
6. A.C. Beekman, A.R. Barentsen, H.J. Woerdenbag, W. van Uden, N. Pras, A.W. Konings, F.S. el-Feraly, A.M. Galal, and H.V. Wikstrom Stereochemistry- dependent cytotoxicity of some artemisinin derivatives J. Nat. Prod. 60 1997 325 330
7. A.C. Beekman, P.K. Wierenga, H.J. Woerdenbag, W. van Uden, N. Pras, A.W. Konings, F.S. el-Feraly, A.M. Galal, and H.V. Wikstrom Artemisinin-derived sesquiterpene lactones as potential antitumour compounds: cytotoxic action against bone marrow and tumour cells Planta Med. 64 1998 615 619
8. Berger, T.G., Dieckmann, D., Efferth, T., Schultz, E.S., Funk, J.-O., Baur, A., Schuler, G. Artesunate in the treatment of metastatic uveal melanoma - first experiences. Oncol. Rep., in press.
9. P.A. Berman, and P.A. Adams Artemisinin enhances hemo-catalyzed oxidation of lipid membranes Free Radic. Biol. Med. 22 1997 1283 1288
10. A.K. Bhattacharjee, and J.M. Karle Stereoelectronic properties of antimalarial artemisinin analogues in relation to neurotoxicity Chem. Res. Toxicol. 12 1999 422 428
11. J. Bhisutthibhan, and S.R. Meshnick Immunoprecipitation of H-3 dihydroartemisinin translationally controlled tumor protein (Tctp) adducts from Plasmodium falciparum-infected erythrocytes by using anti-Tctp antibodies Antimicrob. Agents Chemother. 45 2001 2397 2399
12. U.A. Bommer, and B.J. Thiele The translationally controlled tumour protein (TCTP) Int. J. Biochem. Cell. Biol. 36 2004 379 385
13. T.G. Brewer, S.J. Grate, J.O. Peggins, P.J. Weina, J.M. Petras, B.S. Levine, M.H. Heiffer, and B.G. Schuster Fatal neurotoxicity of arteether and artmether Am. J. Trop. Med. Hyg. 51 1994 251 259
14. H.J. Broxterman, J. Lankelma, and K. Hoekman Resistance to cytotoxic and anti-angiogenic agents: similarities and differences Drug Resist. Update 6 2003 111 127
15. A.R. Butler, and Y.L. Wu Artemisinin (qinghaosu) - a new type of antimalarial drug Chem. Soc. Rev. 21 1992 85 90
16. A.R. Butler, B.C. Gilbert, P. Hulme, L.R. Irvine, L. Renton, and A.C. Whitwood EPR evidence for the involvement of free radicals in the iron-mediated decomposition of qinghaosu (artemisinin) and some derivatives: antimalarial action of some polycyclic endoperoxides Free Radic. Res. 28 1998 471 476
17. P.J. Carder, R. Hume, A.A. Fryer, R.C. Strange, J. Lauder, and J.E. Bell Glutathione S-transferase in human brain Neuropathol. Appl. Neurobiol. 16 1990 293 303
18. H.H. Chen, H.J. Zhou, and X. Fang Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro Pharmacol. Res. 48 2003 231 236
19. H.H. Chen, H.J. Zhou, W.Q. Wang, and G.D. Wu Antimalarial dihydroartemisinin also inhibits angiogenesis Cancer Chemother. Pharmacol. 53 2004 423 432
20. H.H. Chen, H.J. Zhou, G.D. Wu, and X.E. Lou Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1 Pharmacology 71 2004 1 9
21. R. Dell'Eva, U. Pfeffer, R. Vene, L. Anfosso, A. Forlani, A. Albini, and T. Efferth Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate Biochem. Pharmacol. 68 2004 2359 2366
22. U. Eckstein-Ludwig, R.J. Webb, I.D.A. van Goethem, J.M. East, A.G. Lee, M. Kimura, P.M. O'Neill, P.G. Bray, S.A. Ward, and S. Krishna Artemisinins target the Serca of Plasmodium falciparum Nature 424 2003 957 961
23. T. Efferth, G. Rücker, M. Falkenberg, D. Manns, A. Olbrich, U. Fabry, and R. Osieka Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs Arzneimittelforschung 46 1996 196 200
24. T. Efferth, U. Fabry, and R. Osieka Apoptosis and resistance to daunorubicin in human leukemic cells Leukemia 11 1997 1180 1186
25. T. Efferth, H. Dunstan, A. Sauerbrey, H. Miyachi, and C.R. Chitambar The anti-malarial artesunate is also active against cancer Int. J. Oncol. 18 2001 767 773
26. T. Efferth, M. Davey, A. Olbrich, G. Rücker, E. Gebhart, and R. Davey Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells Blood Cells Mol. Dis. 28 2002 160 168
27. T. Efferth, A. Olbrich, and R. Bauer mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether Biochem. Pharmacol. 64 2002 617 623
28. T. Efferth, M. Marschall, X. Wang, S.-M. Huong, I. Hauber, A. Olbrich, M. Kronschnabl, T. Stamminger, and E.-S. Huang Antiviral activity of artesunate towards wild-type, recombinant and ganciclovir-resistant human cytomegaloviruses J. Mol. Med. 80 2002 223 224
29. T. Efferth, A. Sauerbrey, A. Olbrich, E. Gebhart, P. Rauch, H.O. Weber, J.G. Hengstler, M.E. Halatsch, M. Volm, K.D. Tew, D.D. Ross, and J.O. Funk Molecular modes of action of artesunate in tumor cell lines Mol. Pharmacol. 64 2003 382 394
30. T. Efferth, E. Gebhart, D.D. Ross, and A. Sauerbrey Identification of gene expression profiles predicting tumor cell response to l-alanosine Biochem. Pharmacol. 66 2003 613 621
31. T. Efferth, A. Sauerbrey, M.E. Halatsch, D.D. Ross, and E. Gebhart Molecular modes of action of cephalotaxine and homoharringtonine from the Coniferous tree Cephalotaxus hainanensis in human tumor cell lines Naunyn Schmiedebergs Arch. Pharmacol. 367 2003 56 67
32. T. Efferth, M.M. Briehl, and M.E. Tome Role of antioxidant genes for the activity of artesunate against tumor cells Int. J. Oncol. 23 2003 1231 1235
33. T. Efferth, and B. Kaina Microarray-based prediction of cytotoxicity of tumor cells to arsenic trioxide Cancer Genomics Proteomics 1 2004 363 370
34. T. Efferth, T. Ramirez, E. Gebhart, and M.E. Halatsch Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774 Biochem. Pharmacol. 67 2004 1689 1700
35. T. Efferth, A. Benakis, M.R. Romero, M. Tomicic, R. Rauh, D. Steinbach, R. Hafer, T. Stamminger, F. Oesch, B. Kaina, and M. Marschall Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron Free Radic. Biol. Med. 37 2004 998 1009
36. T. Efferth, and F. Oesch Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines Biochem. Pharmacol. 68 2004 3 10
37. Efferth, T. Microarray-based prediction of cytotoxicity of tumor cells to cantharidin. Oncol. Rep., in press.
38. T. Efferth, and M. Volm Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate In Vivo 19 2005 225 232
39. S. Ekthawatchai, S. Kamchonwongpaisan, P. Kongsaeree, B. Tarnchompoo, Y. Thebtaranonth, and Y. Yuthavong C-16 artemisinin derivatives and their antimalarial and cytotoxic activities: syntheses of artemisinin monomers, dimers, trimers, and tetramers by nucleophilic additions to artemisitene J. Med. Chem. 44 2001 4688 4695
40. J. Fishwick, W.G. McLean, G. Edwards, and S.A. Ward The toxicity of artemisinin and related compounds on neuronal and glial cells in culture Chem. Biol. Interact. 96 1995 263 271
41. J. Fishwick, G. Edwards, S.A. Ward, and W.G. McLean Binding of dihydroartemisinin to differentiating neuroblastoma cells and rat cortical homogenate Neurotoxicology 19 1998 405 412
42. J. Fishwick, G. Edwards, S.A. Ward, and W.G. McLean Morphological and immunocytochemical effects of dihydroartemisinin on differentiating NB2a neuroblastoma cells Neurotoxicology 19 1998 393 403
43. J. Folkman The role of angiogenesis in tumor growth Semin. Cancer Biol. 3 1992 65 71
44. S. Fulda, and K.-M. Debatin Apoptosis pathways: turned on their heads? Drug Resist. Update 6 2003 1 3
45. Y. Gachet, S. Tournier, M. Lee, A. Lazaris-Karatzas, T. Poulton, and U.A. Bommer The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle J. Cell Sci. 112 1999 1257 1271
46. A.M. Galal, S.A. Ross, M.A. ElSohly, H.N. ElSohly, F.S. El-Feraly, M.S. Ahmed, and A.T. McPhail Deoxyartemisinin derivatives from photooxygenation of anhydrodeoxydihydroartemisinin and their cytotoxic evaluation J. Nat. Prod. 65 2002 184 188
47. K.C. Gatter, G. Brown, I.S. Trowbridge, R.E. Woolston, and D.Y. Mason Transferrin receptors in human tissues: their distribution and possible clinical relevance J. Clin. Pathol. 36 1983 539 545
48. T. Gordi, and E.I. Lepist Artemisinin derivatives: toxic for laboratory animals, safe for humans? Toxicol. Lett. 147 2004 99 107
49. D.R. Green, and G. Kroemer The pathophysiology of mitochondrial cell death Science 305 2004 626 629
50. S. Haupt, M. Berger, Z. Goldberg, and Y. Haupt Apoptosis - the p53 network J. Cell Sci. 116 116 2003 4077 4085
51. R.K. Haynes Artemisinin and derivatives: the future for malaria treatment? Curr. Opin. Infect. Dis. 14 2001 719 726
52. W. Hofheinz, H. Burgin, E. Gocke, C. Jaquet, R. Masciadri, G. Schmid, H. Stohler, and H. Urwyler Ro-42-1611 (arteflene), a new effective antimalarial - chemical structure and biological activity Trop. Med. Parasitol. 45 1994 261 265
53. C. Huan-Huan, Y. Li-Li, and L. Shang-Bin Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell Cancer Lett. 211 2004 163 173
54. A.I. Ivanov, J. Christodoulou, J.A. Parkinson, K.J. Barnham, A. Tucker, J. Woodrow, and P.J. Sadler Cisplatin binding sites on human albumin J. Biol. Chem. 273 1998 14721 14730
55. J.P. Jeyadevan, P.G. Bray, J. Chadwick, A.E. Mercer, A. Byrne, S.A. Ward, B.K. Park, D.P. Williams, R. Cosstick, J. Davies, A.P. Higson, E. Irving, G.H. Posner, and P.M. O'Neill Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin J. Med. Chem. 47 2004 1290 1298
56. W. Judd, C.A. Poodry, and J.L. Strominger Novel surface antigen expressed on dividing cells but absent from nondividing cells J. Exp. Med. 152 1980 1430 1435
57. S. Kamchonwongpaisan, P. McKeever, P. Hossler, H. Ziffer, and S.R. Meshnick Artemisinin neurotoxicity: neuropathology in rats and mechanistic studies in vitro Am. J. Trop. Med. Hyg. 56 1997 7 12
58. R. Kerbel, and J. Folkman Clinical translation of angiogenesis inhibitors Nat. Rev. Cancer 2 2002 727 739
59. S.H. Kim, H.J. Kim, and T.S. Kim Differential involvement of protein kinase C in human promyelocytic leukemia cell differentiation enhanced by artemisinin Eur. J. Pharmacol. 482 2003 67 76
60. D.L. Klayman Qinghaosu (artemisinin) - an antimalarial drug from China Science 228 1985 1049 1055
61. S. Krishna, A.-C. Uhlemann, and R.K. Haynes Arteminisins: mechanisms of action and potential for resistance Drug Resist. Update 7 2004 233 244
62. H. Lai, T. Sasaki, N.P. Singh, and A. Messay Effects of artemisinin-tagged holotransferrin on cancer cells Life Sci. 76 2005 1267 1279
63. C.H. Lee, H. Hong, J. Shin, M. Jung, I. Shin, J. Yoon, and W. Lee NMR studies on novel antitumor drug candidates, deoxoartemisinin and carboxypropyldeoxoartemisinin Biochem. Biophys. Res. Commun. 274 2000 359 369
64. F. Leteurtre, G. Kohlhagen, K.D. Paull, and Y. Pommier Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen J. Natl. Cancer Inst. 86 1994 1239 1244
65. Y. Li, F. Shan, J.M. Wu, G.S. Wu, J. Ding, D. Xiao, W.Y. Yang, G. Atassi, S. Leonce, D.H. Caignard, and P. Renard Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle Bioorg. Med. Chem. Lett. 11 2001 5 8
66. Y. Li, J.M. Wu, F. Shan, G.S. Wu, J. Ding, D. Xiao, J.X. Han, G. Atassi, S. Leonce, D.H. Caignard, and P. Renard Synthesis and cytotoxicity of dihydroartemisinin ethers containing cyanoarylmethyl group Bioorg. Med. Chem. 11 2003 977 984
67. R. Mandal, R. Kalke, and X.F. Li Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group Chem. Res. Toxicol. 17 2004 1391 1397
68. M.F. McCarty Turning an 'Achilles' Heel' into an asset-activation of HIF-1alpha during angiostatic therapy will increase tumor sensitivity to iron-catalyzed oxidative damage Med. Hypotheses 61 2003 509 511
69. W.G. McLean, and S.A. Ward In vitro neurotoxicity of artemisinin derivatives Med. Trop. (Mars) 58 1998 28 31
70. S.R. Meshnick, Y.Z. Yang, V. Lima, F. Kuypers, S. Kamchonwongpaisan, and Y. Yuthavong Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu) Antimicrob. Agents Chemother. 37 1993 1108 1114
71. J.C. Moore, H. Lai, J.R. Li, R.L. Ren, J.A. McDougall, N.P. Singh, and C.K. Chou Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat Cancer Lett. 98 1995 83 87
72. S. Mukanganyama, Y.S. Naik, M. Widersten, B. Mannervik, and J.A. Hasler Proposed reductive metabolism of artemisinin by glutathione transferases in vitro Free Radic. Res. 35 2001 427 434
73. S. Mukanganyama, M. Widersten, Y.S. Naik, B. Mannervik, and J.A. Hasler Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance Int. J. Cancer 97 2002 700 705
74. I. Naasani, H. Seimiya, T. Yamori, and T. Tsuruo FJ5002: a potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis Cancer Res. 59 1999 4004 4011
75. M. Nagane, F. Coufal, H. Lin, O. Bögler, W.K. Cavenee, and H.J.S. Huang A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis Cancer Res. 56 1996 5079 5086
76. S. Oh, I.H. Jeong, C.M. Ahn, W.S. Shin, and S. Lee Synthesis and antiangiogenic activity of thioacetal artemisinin derivatives Bioorg. Med. Chem. 12 2004 3783 3790
77. P.M. O'Neill, and G.H. Posner A medicinal chemistry perspective on artemisinin and related endoperoxides J. Med. Chem. 47 2004 2945 2964
78. I. Pankova-Kholmyansky, A. Dagan, D. Gold, Z. Zaslavsky, E. Skutelsky, S. Gatt, and E. Flescher Ceramide mediates growth inhibition of the Plasmodium falciparum parasite Cell. Mol. Life Sci. 60 2003 577 587
79. S. Parapini, N. Basilico, M. Mondani, P. Olliaro, D. Taramelli, and D. Monti Evidence that haem iron in the malaria parasite is not needed for the antimalarial effects of artemisinin FEBS Lett. 575 2004 91 94
80. K.D. Paull, C.M. Lin, L. Malspeis, and E. Hamel Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data Cancer Res. 52 1992 3892 3900
81. A.G. Payne Exploiting intracellular iron and iron-rich compounds to effect tumor cell lysis Med. Hypotheses 61 2003 206 209
82. T. Peleg-Shulman, Y. Najajreh, and D. Gibson Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles J. Inorg. Biochem. 91 2002 306 311
83. Y. Pommier, O. Sordet, S. Antony, R.L. Hayward, and K.W. Kohn Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks Oncogene 23 2004 2934 2949
84. G.H. Posner, A.J. McRiner, I.H. Paik, S. Sur, K. Borstnik, S. Xie, T.A. Shapiro, A. Alagbala, and B. Foster Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents J. Med. Chem. 47 2004 1299 1301
85. G.H. Posner, and C.H. Oh A regiospecifically O-18 labeled 1,2,4-trioxane, a simple chemical-model system to probe the mechanism(s) for the antimalarial activity of artemisinin (qinghaosu) J. Am. Chem. Soc. 114 1992 8328 8329
86. G.H. Posner, P. Ploypradith, M.H. Parker, H. O'Dowd, S.H. Woo, J. Northrop, M. Krasavin, P. Dolan, T.W. Kensler, S. Xie, and T.A. Shapiro Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers J. Med. Chem. 42 1999 4275 4280
87. G.H. Posner, J. Northrop, I.H. Paik, K. Borstnik, P. Dolan, T.W. Kensler, S. Xie, and T.A. Shapiro New chemical and biological aspects of artemisinin-derived trioxane dimers Bioorg. Med. Chem. 10 2002 227 232
88. R. Price, M. van Vugt, F. Nosten, C. Luxemburger, A. Brockman, L. Phaipun, T. Chongsuphajaisiddhi, and N. White Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria Am. J. Trop. Med. Hyg. 59 1998 883 888
89. R. Ravi, and A. Bedi NF-κB in cancer - a friend turned foe Drug Resist. Update 7 2004 53 67
90. M. Relf, S. LeJeune, P.A. Scott, S. Fox, K. Smith, R. Leek, A. Moghaddam, R. Whitehouse, R. Bicknell, and A.L. Harris Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis Cancer Res. 57 1997 963 969
91. P. Reungpatthanaphong, and S. Mankhetkorn Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines Biol. Pharm. Bull. 25 2002 1555 1561
92. I.R. Ribeiro, and P. Olliaro Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials Med. Trop. (Mars) 58 3 Suppl. 1998 50 53
93. B. Rinner, V. Siegl, P. Pürstner, T. Efferth, B. Brem, H. Greger, and R. Pfragner Activity of novel plant extracts against medullary thyroid carcinoma cells Anticancer Res. 24 2004 495 500
94. D. Sadava, T. Phillips, C. Lin, and S.E. Kane Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells Cancer Lett. 179 2002 151 156
95. A.D. Schimmer, D.W. Hedley, L.Z. Penn, and M. Minden Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view Blood 98 2001 3541 3553
96. G. Schmuck, E. Roehrdanz, R.K. Haynes, and R. Kahl Neurotoxic mode of action of artemisinin Antimicrob. Agents Chemother. 46 2002 821 827
97. A. Semenov, J.E. Olson, and P.J. Rosenthal Antimalarial synergy of cysteine and aspartic protease inhibitors Antimicrob. Agents Chemother. 42 1998 2554 2558
98. S. Shankar, and R.K. Srivastava Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications Drug Resist. Update 7 2004 139 156
99. B.R. Shenai, P.S. Sijwali, A. Singh, and P.J. Rosenthal Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum J. Biol. Chem. 275 2000 29000 29010
100. L.M. Shi, T.G. Myers, Y. Fan, P.M. O'Connor, K.D. Paull, S.H. Friend, and J.N. Weinstein Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity Mol. Pharmacol. 53 1998 241 251
101. K. Shimizu, and N. Oku Cancer anti-angiogenic therapy Biol. Pharm. Bull. 27 2004 599 605
102. N. Shterman, B. Kupfer, and C. Moroz Comparison of transferrin receptors, iron content and isoferritin profile in normal and malignant human breast cell lines Pathobiology 59 1991 19 25
103. N.J. Siddiqi, and V.C. Pandey Studies on hepatic oxidative stress and antioxidant defence systems during arteether treatment of Plasmodium yoelii nigeriensis infected mice Mol. Cell. Biochem. 196 1999 169 173
104. B. Siedle, A.J. Garcia-Pineres, R. Murillo, J. Schulte-Monting, V. Castro, P. Rungeler, C.A. Klaas, F.B. Da Costa, W. Kisiel, and I. Merfort Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB J. Med. Chem. 47 2004 6042 6054
105. N.P. Singh, and H. Lai Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells Life Sci. 70 2001 49 56
106. N.P. Singh, and H.C. Lai Artemisinin induces apoptosis in human cancer cells Anticancer Res. 24 2004 2277 2280
107. N.P. Singh, and K.B. Verma Case report of a laryngeal squamous cell carcinoma treated with artesunate Arch. Oncol. 10 2002 279 280
108. S.L. Smith, J.L. Maggs, G. Edwards, S.A. Ward, B.K. Park, and W.G. McLean The role of iron in neurotoxicity: a study of novel antimalarial drugs Neurotoxicology 19 1998 557 559
109. S.L. Smith, C.J. Sadler, C.C. Dodd, G. Edwards, S.A. Ward, B.K. Park, and W.G. McLean The role of glutathione in the neurotoxicity of artemisinin derivatives in vitro Biochem. Pharmacol. 61 2001 409 416
110. W.S. Sun, J.X. Han, W.Y. Yang, D.A. Deng, and X.F. Yue Antitumor activities of 4 derivatives of artemisic acid and artemisinin B in vitro Acta Pharmacol. Sin. 13 1992 541 543
111. R. Sutherland, D. Delia, C. Schneider, R. Newman, J. Kemshead, and M. Greaves Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin Proc. Natl. Acad. Sci. U.S.A. 78 1981 4515 4519
112. R.X. Tan, W.F. Zheng, and H.Q. Tang Biologically active substances from the genus Artemisia Planta Med. 64 1998 295 302
113. I.S. Trowbridge, and M.B. Omary Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin Proc. Natl. Acad. Sci. U.S.A. 78 1981 3039 3043
114. M. Volm, R. Koomägi, J. Mattern, and T. Efferth Protein expression profiles indicative for drug resistance of non-small cell lung cancer Br. J. Cancer 87 2002 251 257
115. M. Volm, R. Koomägi, J. Mattern, and T. Efferth Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients Clin. Cancer Res. 8 2002 1843 1848
116. D.J. Walker, J.L. Pitsch, M.M. Peng, B.L. Robinson, W. Peters, J. Bhisutthibhan, and S.R. Meshnick Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii Antimicrob. Agents Chemother. 44 2000 344 347
117. M.E. Wall, and M.C. Wani Camptothecin and taxol: discovery to clinic - thirteenth Bruce F. Cain Memorial Award Lecture Cancer Res. 55 1995 753 760
118. Q. Wang, L.M. Wu, Y. Zhao, X.L. Zhang, and N.P. Wang The anticancer effect of artesunate and its mechanism Yao Xue Xue Bao 37 2002 477 478
119. M. Wartenberg, S. Wolf, P. Budde, F. Grunheck, H. Acker, J. Hescheler, G. Wartenberg, and H. Sauer The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies Lab. Invest. 83 2003 1647 1655
120. H.J. Woerdenbag, T.A. Moskal, N. Pras, T.M. Malingre, F.S. el-Feraly, H.H. Kampinga, and A.W. Konings Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells J. Nat. Prod. 56 1993 845 849
121. K. Wosikowski, D. Schuurhuis, K. Johnson, K.D. Paull, T.G. Myers, J.N. Weinstein, and S.E. Bates Identification of epidermal growth factor receptor and erbB2 pathway inhibitors by correlation with gene expression patterns J. Natl. Cancer Inst. 89 1997 1505 1515
122. B.G. Wouters, T. van den Beucken, M.G. Magagnin, P. Lambin, and C. Koumenis Targeting hypoxia tolerance in cancer Drug Resist. Update 7 2004 25 40
123. J.M. Wu, F. Shan, G.S. Wu, Y. Li, J. Ding, D. Xiao, J.X. Han, G. Atassi, S. Leonce, D.H. Caignard, and P. Renard Synthesis and cytotoxicity of artemisinin derivatives containing cyanoarylmethyl group Eur. J. Med. Chem. 36 2001 469 479
124. E. Yamachika, T. Habte, and D. Oda Artemisinin: an alternative treatment for oral squamous cell carcinoma Anticancer Res. 24 2004 2153 2160
125. Y.Z. Yang, B. Little, and S.R. Meshnick Alkylation of proteins by artemisinin. Effects of heme, pH, and drug structure Biochem. Pharmacol. 48 1994 569 573
126. J.L. Yu, B.L. Coomber, and R.S. Kerbel A paradigm for therapy-induced microenvironmental changes in solid tumors leading to drug resistance Differentiation 70 2002 599 609
127. F. Zhang, D.K. Gosser, and S.R. Meshnick Hemin-catalyzed decomposition of artemisinin (qinghaosu) Biochem. Pharmacol. 43 1992 1805 1809
128. G.Q. Zheng Cytotoxic terpenoids and flavonoids from Artemisia annua Planta Med. 60 1994 54 57